Spi-1 is a putative oncogene in virally induced murine erythroleukaemias
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Retroviral insertional mutagenesis has been proposed as an efficient mechanism to turn on or to increase the expression of oncogenes in several avian or mammal models. Integration site studies of avian leukosis virus, murine leukaemia and murine mammary tumour viruses led to the coleutification of highly conserved genes whose expression is induced or increased during leukaemogenesis, probably through enhancer elements present in the retroviral long terminal repeats. This is reminiscent of the activation of cellular proto-oncogenes or putative oncogenes in numerous human tumours and leukaemias as a result of chromosomal translocations or DNA rearrangements. Here we report the characterization of a new putative oncogene isolated from a murine erythroleukaemia induced by the acute leukaemogenic retrovirus spleen focus forming virus (SFFV). An important and unusual feature of this genomic locus Spi-1 (for SFFV proviral integration) is that rearrangements due to SFFV integration were found in 95% of the erythroid tumours studied. A 4.0-kilobase messenger RNA was detected in rearranged tumours. No Spi-1 rearrangement was detected in other virally induced myeloid, lymphoid or erythroid tumours tested.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aberrant expression of PU.1 inhibits erythroid cell differentiation and contributes to the formation of murine erythroleukemias (MEL).”
From Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1 (2002) · cites this paper as [50]
In the citing paper
“However, CellOracle did not detect a previously reported depletion of erythrocyte progenitors after Spi1 KO27,28, probably owing to changes in cell proliferation that are not predicted by the method.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [28]
In the citing paper
“PU.1 (Spi-1), a member of this family, is encoded by proto-oncogene sfpi-1 and is expressed exclusively in haematopoietic cells, with high levels detected in monocytic, granulocytic and B lymphoid lineages [16–20].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [16]
In the citing paper
“PU.1 is an Ets-family transcription factor which controls many critical genes important for the development of white cells within the hematopoietic system, in particular, myeloid and B cells”
From Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element (2005) · cites this paper as [34]
In the citing paper
“The SFFV provirus integration sites span several kilobases approximately 14 kb 5Ј of the PU.1 coding region (34,44).”
From Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element (2005) · cites this paper as [34]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Nusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Theo Cuypers, H., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., & Berns, A. (1984) · Cell · doi:10.1016/0092-8674(84)90309-x · Cited by 639
Novel bacteriophage lambda cloning vector.
Karn, J., Brenner, S., Barnett, L., & Cesareni, G. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5172 · Cited by 386
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
Mowat, M., Cheng, A., Kimura, N., Bernstein, A., & Benchimol, S. (1985) · Nature · doi:10.1038/314633a0 · Cited by 320
Peters, G., Brookes, S., Smith, R., & Dickson, C. (1983) · Cell · doi:10.1016/0092-8674(83)90418-x · Cited by 320
Fung, Y.-K. T., Lewis, W. G., Crittenden, L. B., & Kung, H.-J. (1983) · Cell · doi:10.1016/0092-8674(83)90417-8 · Cited by 281
Activation of the c- myb Locus by Viral Insertional Mutagenesis in Plasmacytoid Lymphosarcomas
Shen-Ong, G. L. C., Potter, M., Mushinski, J. F., Lavu, S., & Reddy, E. P. (1984) · Science · doi:10.1126/science.6093260 · Cited by 143
Specific integration of REV proviruses in avian bursal lymphomas
Noori-Daloii, M.-R., Swift, R. A., Kung, H.-J., Crittenden, L. B., & Witter, R. L. (1981) · Nature · doi:10.1038/294574a0 · Cited by 130
Linemeyer, D. L., Menke, J. G., Ruscetti, S. K., Evans, L. H., & Scolnick, E. M. (1982) · Journal of Virology · doi:10.1128/jvi.43.1.223-233.1982 · Cited by 110
Cited by
Items 101–200 of 454
Himmelmann, A., Riva, A., Wilson, G. L., Lucas, B. P., Thevenin, C., & Kehrl, J. H. (1997) · Blood · doi:10.1182/blood.v90.10.3984 · Cited by 68
The Ets-related transcription factor PU.1 immortalizes erythroblasts.
Schuetze, S., Stenberg, P. E., & Kabat, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5670 · Cited by 87
PU.1 can participate in an active enhancer complex without its transcriptional activation domain
Pongubala, J. M. R., & Atchison, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.127 · Cited by 86
Ladomery, M. (1997) · BioEssays · doi:10.1002/bies.950191010 · Cited by 94
Schuetze, S., Paul, R., Gliniak, B. C., & Kabat, D. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.7.2967 · Cited by 85
Metz, T., & Graf, T. (1991) · Genes & Development · doi:10.1101/gad.5.3.369 · Cited by 88
NONO and tumorigenesis: More than splicing
Feng, P., Li, L., Deng, T., Liu, Y., Ling, N., Qiu, S., Zhang, L., Peng, B., Xiong, W., Cao, L., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15141 · Cited by 86
Perez, C., Coeffier, E., Moreau-Gachelin, F., Wietzerbin, J., & Benech, P. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5023 · Cited by 84
“1/Spi-1 (9, 18, 22,35) and Spi-B (34) detected in B cells and”
Self-citationBen‐David, Y., Bani, M. R., Chabot, B., de Koven, A., & Bernstein, A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4449-4455.1992 · Cited by 91
“have identified a common site for retroviral integration named Spi-1 (SFFV provirus integration-1) and shown that this locus is rearranged in the majority of the erythroleukemia cell lines induced by the FV-P and FV-A strains of Friend leukemia virus (24, 25).”
BackgroundSingh, H. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80053-7 · Cited by 88
Do lampreys have lymphocytes? The Spi evidence
Shintani, S., Terzić, J., Sato, A., Saraga‐Babić, M., Ó’hUigín, C., Tichy, H., & Klein, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110505597 · Cited by 86
Wei, Y., Fourel, G., Ponzetto, A., Silvestro, M., Tiollais, P., & Buendia, M. (1992) · Journal of Virology · doi:10.1128/jvi.66.9.5265-5276.1992 · Cited by 80
Heberlein, C., Fischer, K. D., Stoffel, M., Nowock, J., Ford, A., Tessmer, U., & Stocking, C. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1815 · Cited by 80
A Two-Step Mechanism for Recruitment of Pip by PU.1
Perkel, J. M., & Atchison, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.241 · Cited by 77
PU.1 and Haematopoietic Cell Fate: Dosage Matters
Mak, K. S., Funnell, A. P. W., Pearson, R. C. M., & Crossley, M. (2011) · International Journal of Cell Biology · doi:10.1155/2011/808524 · Cited by 77
“1 locus and transcriptionally activates the gene, resulting in erythroblast transformation [1, 24].”
BackgroundRobertson, S. J., Ammann, C. G., Messer, R. J., Carmody, A., Myers, L. M., Dittmer, U., Nair, S., Gerlach, N., Evans, L. H., Cafruny, W. A., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01413-07 · Cited by 77
“Second, the full transformation of cells to the leukemic state in Friend virus (FV)-infected mice is associated with SFFV provirus integration into both the Spi-1 proto-oncogene (44) and the p53 tumor suppressor gene (46).”
Starck, J., Doubeikovski, A., Sarrazin, S., Gonnet, C., Rao, G., Skoultchi, A., Godet, J., Dusanter-Fourt, I., & Morle, F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.121 · Cited by 74
Matushansky, I., Radparvar, F., & Skoultchi, A. I. (2003) · Oncogene · doi:10.1038/sj.onc.1206484 · Cited by 88
“Inappropriate expression of PU.1 because of proviral insertion in erythroid precursors is a central event in the generation of these erythroleukemias (Moreau-Gachelin et al., 1988; Paul et al., 1989).”
BackgroundPak, B. J., Lee, J., Thai, B., Fuchs, S. Y., Shaked, Y., Ronai, Z. A., Kerbel, R. S., & Ben‐David, Y. (2004) · Oncogene · doi:10.1038/sj.onc.1207007 · Cited by 75
“…to identify several genes associated with malignant transformation and tumor progression of murine cells including Fli-1, Spi-1, p53 and NF-E2/p45 (Mowat et al., 1985; Ben-David et al., 1988; Moreau-Gachelin et al., 1988; Ben-David and Bernstein, 1991; Ben-David et al., 1991; Lu et al., 1994).”
BackgroundMechanism of leukemogenesis induced by mink cell focus-forming murine leukemia viruses
Li, J. P., & Baltimore, D. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2408-2414.1991 · Cited by 75
“oncogene(s) (47) and to the development of leukemia.”
BackgroundGupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74
Role of Transcription Factors C/EBPa and PU.1 in Normal Hematopoiesis and Leukemia
Koschmieder, S., Rosenbauer, F., Steidl, U., Owens, B. M., & Tenen, D. G. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05051 · Cited by 72
“Overexpression of PU.1 contributes to the development of erythroleukemia in a Friend leukemia virus mouse model by a mechanism that most likely includes inhibition of GATA-1 [40, 43-45 ].”
BackgroundInhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1
Hong, W., Kim, A. Y., Ky, S., Rakowski, C., Seo, S.-B., Chakravarti, D., Atchison, M., & Blobel, G. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3729-3743.2002 · Cited by 74
“1 expression occurs at the same stage at which GATA-1-deficient erythroid cells are arrested (50, 77), suggesting that GATA-1 is a biologically relevant target of PU.”
BackgroundPU.1 Is Essential for p47 Promoter Activity in Myeloid Cells
Li, S.-L., Valente, A. J., Zhao, S.-J., & Clark, R. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17802 · Cited by 72
Deregulation of erythropoiesis by the Friend spleen focus-forming virus
Ruscetti, S. K. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00074-6 · Cited by 75
Dittmer, U., Brooks, D. M., & Hasenkrug, K. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6554-6558.1998 · Cited by 70
Virus-Host Interactions and the Pathogenesis of Murine and Human Oncogenic Retroviruses
Tsichlis, P. N., & Lazo, P. A. (1991) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-76524-7_5 · Cited by 75
Yang, F., Gao, Z., Xu, J., Wang, H., Guo, Q., Li, B., Li, M., Xu, H., Qi, Y., Zhao, S., et al. (2023) · Theranostics · doi:10.7150/thno.82590 · Cited by 73
“In tumors, SPI1 was initially studied more frequently in leukemia, but SPI1 was later reported to play a promoting role in other cancers [59-61].”
BackgroundReview: The Role of IRF-4 in Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452737 · Cited by 67
“This wHTH transcription factor (47,48) was identified by Moreau-Gachelin et al. (49) during studies of Friend spleen focus-forming virus-infected mice.”
Normal and leukaemic stem cells
Bonnet, D. A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05596.x · Cited by 78
“…transcription factors have been identified through their involvement in leukaemias, either as a result of abnormal expression, such as PU.1, WT-1 (Moreau-Gachelin et al, 1998; Miwa et al, 1992), or through their consistent involvement at the site of chromosomal translocations (examples include…”
BackgroundPU.1, a Shared Transcriptional Regulator of Lymphoid and Myeloid Cell Fates
SINGH, H., DEKOTER, R. P., & WALSH, J. C. (1999) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1999.64.13 · Cited by 66
Oncogenes at viral integration sites.
Peters, G. B. (1990) · PubMed · Cited by 65
Ye, Z., Wang, F., Yan, F., Wang, L., Li, B., Liu, T., Hu, F., Jiang, M., Li, W., & Fu, Z. (2019) · World Journal of Surgical Oncology · doi:10.1186/s12957-019-1605-9 · Cited by 64
BSAP Can Repress Enhancer Activity by Targeting PU.1 Function
Maitra, S., & Atchison, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.1911-1922.2000 · Cited by 64
Lakhanpal, G. K., Vecchiarelli-Federico, L. M., Li, Y.-J., Cui, J.-W., Bailey, M. L., Spaner, D. E., Dumont, D. J., Barber, D. L., & Ben-David, Y. (2010) · Blood · doi:10.1182/blood-2009-10-250217 · Cited by 60
Dittmer, U., Peterson, K. E., Messer, R., Stromnes, I. M., Race, B., & Hasenkrug, K. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.654-660.2001 · Cited by 62
Effects of Type I Interferons on Friend Retrovirus Infection
Gerlach, N., Schimmer, S., Weiss, S., Kalinke, U., & Dittmer, U. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3438-3444.2006 · Cited by 59
“In susceptible strains, the disease progresses to lethal erythroleukemia, whereas resistant mice, such as C57BL/6 (B6), control the erythroblast proliferation ( 25 , 27, 40).”
BackgroundFriend erythroleukemia revisited
Ney, P. A., & D’Andrea, A. D. (2000) · Blood · doi:10.1182/blood.v96.12.3675 · Cited by 61
Anti‐retroviral effects of type I IFN subtypes in vivo
Gerlach, N., Sutter, K., Alter, C., Nair, S., Zelinskyy, G., James, C. M., & Dittmer, U. (2009) · European Journal of Immunology · doi:10.1002/eji.200838311 · Cited by 60
Octamer Binding Factors and Their Coactivator Can Activate the Murine PU.1 (spi-1) Promoter
Chen, H.-M., Zhang, P., Radomska, H. S., Hetherington, C. J., Zhang, D.-E., & Tenen, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15743 · Cited by 59
Ellis, S. L., Gysbers, V., Manders, P. M., Li, W., Hofer, M. J., Müller, M., & Campbell, I. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000900 · Cited by 58
“gene was originally discovered as a consequence of insertional activation by the murine retrovirus spleen focus-forming virus (54).”
BackgroundBosselut, R., Levin, J., Adjadj, E., & Ghysdael, J. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.22.5184 · Cited by 56
Functional interference between the Spi‐1/PU.1 oncoprotein and steroid hormone or vitamin receptors.
Gauthier, J. M., Bourachot, B., Doucas, V., Yaniv, M., & Moreau-Gachelin, F. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06203.x · Cited by 62
Self-citationPU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells
Federzoni, E. A., Valk, P. J. M., Torbett, B. E., Haferlach, T., Löwenberg, B., Fey, M. F., & Tschan, M. P. (2012) · Blood · doi:10.1182/blood-2011-09-378117 · Cited by 55
Insertional Oncogenesis by Non-Acute Retroviruses: Implications for Gene Therapy
Fan, H., & Johnson, C. (2011) · Viruses · doi:10.3390/v3040398 · Cited by 60
“Pim-1 is a serine-threonine kinase, and Spi-1 (PU.1) and Fli-1 are transcription factors of the Ets family.”
Human Proteinase-3 Expression Is Regulated by PU.1 in Conjunction with a Cytidine-rich Element
Sturrock, A., Franklin, K. F., & Hoidal, J. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32392 · Cited by 55
Paul, R., Schuetze, S., Kozak, S. L., & Kabat, D. (1989) · Journal of Virology · doi:10.1128/jvi.63.11.4958-4961.1989 · Cited by 55
“The clonal aspects of progression have also been difficult to analyze because SFFV contains only murine leukemia virusrelated nucleic acid sequences that are present in many copies in the normal mouse genome (3, 16-18).”
BackgroundInfluentialTatetsu, H., Ueno, S., Hata, H., Yamada, Y., Takeya, M., Mitsuya, H., Tenen, D. G., & Okuno, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4265 · Cited by 51
“1 transcription start site, resulting in erythroleukemia in mice (1).”
BackgroundFinkelstein, L. D., Ney, P. A., Liu, Q.-P., Paulson, R. F., & Correll, P. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205442 · Cited by 55
“In the later stages, fully transformed clones emerge that contain additional genetic mutations, leading to the development of erythroleukemia (Moreau-Gachelin et al., 1988; Mowat et al., 1985).”
BackgroundVegesna, V., Takeuchi, S., Hofmann, W.-K., Ikezoe, T., Tavor, S., Krug, U., Fermin, A. C., Heaney, A., Miller, C. W., & Koeffler, H. P. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00150-3 · Cited by 54
“1 and development of erythroleukemia [17].”
BackgroundAnalysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models
DeKoter, R. P., Kamath, M. B., & Houston, I. B. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.06.004 · Cited by 63
“1 was first described in 1988 as a gene dysregulated by proviral insertion of the spleen focus forming virus (SFFV) in murine erythroleukemia [1].”
BackgroundQuang, C. T., Wessely, O., Pironin, M., Beug, H., & Ghysdael, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5639 · Cited by 58
Wontakal, S. N., Guo, X., Will, B., Shi, M., Raha, D., Mahajan, M. C., Weissman, S., Snyder, M., Steidl, U., Zheng, D., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001392 · Cited by 53
“1 is also a frequent target for integration by the spleen-focus-forming virus during Friend leukemia virus-induced murine erythroleukemia (MEL) [16].”
BackgroundGangenahalli, G. U., Gupta, P., Saluja, D., Verma, Y. K., Kishore, V., Chandra, R., Sharma, R. K., & Ravindranath, T. (2005) · Stem Cells and Development · doi:10.1089/scd.2005.14.140 · Cited by 53
Host genetic factors that control immune responses to retrovirus infections
Miyazawa, M., Tsuji-Kawahara, S., & Kanari, Y. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.004 · Cited by 53
“Rapid expansion in the number f erythroid progenitor cells is believed to provide a large nough pool of target cells for repeated integration of FFV and F-MuLV proviruses, and resultantly increases the hances for the proviruses to ‘‘hit’’ cellular genes by the romoter insertion adjacent to an oncogene or by the disupt…”
p53 mutations in human tumors with chimeric EWS/FLI/1 genes
Hamelin, R., Zucman‐Rossi, J., Melot, T., Delatre, O., & Thomas, G. D. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570308 · Cited by 53
Aizawa, S., Suda, Y., Furuta, Y., Yagi, T., Takeda, N., Watanabe, N., Nagayoshi, M., & Ikawa, Y. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07379.x · Cited by 52
Hasenkrug, K. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6468-6473.1999 · Cited by 72
“The requirement for SFFV in the induction of erythroleukemia in the T-cell-deficient, Fv-2-resistant mice is interesting since there was no early expansion of target cells induced by SFFV gp55 (Fig. 2, 3, and 5 and Table 1). The relatively long latency before erythroleukemia induction could reflect the extra time requ…”
BackgroundSola, B., Simon‐Chazottes, D., Mattéi, M., Fichelson, S., Bordereaux, D., Tambourin, P. E., Guénet, J., & Gisselbrecht, S. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.3973-3978.1988 · Cited by 51
Self-citationKozak, C. A., & Ruscetti, S. K. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3372-6_7 · Cited by 53
Retroviruses and Their Role in Cancer
Fan, H. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1730-0_7 · Cited by 56
Verbiest, T., Bouffler, S., Nutt, S. L., & Badie, C. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv016 · Cited by 46
“1 overexpression inhibits erythroid lineage maturation, eventually resulting in erythroleukaemia (51).”
BackgroundKosmider, O., Denis, N., Lacout, C., Vainchenker, W., Dubreuil, P., & Moreau-Gachelin, F. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.11.009 · Cited by 49
Self-citationDrug-mediated inhibition of Fli-1 for the treatment of leukemia
Yj, L., Zhao, X., Vecchiarelli-Federico, L. M., Li, Y., Datti, A., Cheng, Y., & Ben‐David, Y. (2012) · Blood Cancer Journal · doi:10.1038/bcj.2011.52 · Cited by 49
Epigenetic control of hematopoiesis: the PU.1 chromatin connection
van Riel, B., & Rosenbauer, F. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0195 · Cited by 48
Barth-Baus, D. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.1919 · Cited by 46
The ETS Family of Transcriptional Regulators
Ghysdael, J., & Boureux, A. (1997) · Oncogenes as Transcriptional Regulators · doi:10.1007/978-3-0348-8889-9_2 · Cited by 48
Curik, N., Burda, P., Vargová, K., Pospíšil, V., Beličková, M., Vlckova, P., Savvulidi, F. G., Nečas, E., Hajkova, H., Haškovec, C., et al. (2012) · Leukemia · doi:10.1038/leu.2012.47 · Cited by 48
Concise Review: Erythroid Versus Myeloid Lineage Commitment: Regulating the Master Regulators
Wolff, L., & Humeniuk, R. (2013) · Stem Cells · doi:10.1002/stem.1379 · Cited by 41
O'Prey, J., Ramsay, S., Chambers, I., & Harrison, P. R. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6290 · Cited by 46
Bergeron, D., Poliquin, L., Kozak, C. A., & Rassart, É. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.7-15.1991 · Cited by 46
“Such an experimental approach has been fruitful in identifying proto-oncogenes or potential protooncogenes in murine tumors such as Int-i, Int-2, Int-3, and Int4i in mouse mammary tumor virus-induced mammary carcinomas (13, 14, 38, 40); N-myc, Myc, Pim-J, Pim-2, Mlvi-ilMis-ilPvt-i, Mlvi-2, Gin-i, Dsi-i, Fis-1, Tpl-i,…”
Lévesque, K., Bonham, L., & Levy, L. (1990) · Journal of Virology · doi:10.1128/jvi.64.7.3455-3462.1990 · Cited by 46
Galson, D. L., Hensold, J. O., Bishop, T. R., Schalling, M., D'Andrea, A. D., Jones, C., Auron, P. E., & Housman, D. E. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.5.2929-2941.1993 · Cited by 45
Mouse models for radiation-induced cancers
Rivina, L., Davoren, M. J., & Schiestl, R. H. (2016) · Mutagenesis · doi:10.1093/mutage/gew019 · Cited by 46
The PU.1 transcription factor is the product of the putative oncogene Spi-1
Moreau-Gachelin, F., Ray-Gallet, D., Tambourin, P. E., Tavitian, A., Klemsz, M. J., McKercher, S. R., Celada, A., Beveren, C. V., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90677-7 · Cited by 49
Self-citationGATA-1 directly regulates p21 gene expression during erythroid differentiation
Papetti, M., Wontakal, S. N., Stopka, T., & Skoultchi, A. I. (2010) · Cell Cycle · doi:10.4161/cc.9.10.11602 · Cited by 54
Modeling and targeting of erythroleukemia by hematopoietic genome editing
Iacobucci, I., Qu, C., Varotto, E., Janke, L. J., Xu, Y., Seth, A., Shelat, A. A., Friske, J. D., Fukano, R., Yu, J., et al. (2021) · Blood · doi:10.1182/blood.2020009103 · Cited by 47
Temporal Effects of Gamma Interferon Deficiency on the Course of Friend Retrovirus Infection in Mice
Stromnes, I. M., Dittmer, U., Schumacher, T. N., Schepers, K., Messer, R. J., Evans, L. H., Peterson, K. E., Race, B., & Hasenkrug, K. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2225-2232.2002 · Cited by 44
“In the absence of protective immune responses, SFFV eventually integrates into the Spi-1 oncogene and into the p53 tumor suppressor gene to induce erythroleukemia ( 39 , 41).”
Immune Control and Prevention of Chronic Friend Retrovirus Infection
Kim, J.-O. (2006) · Frontiers in bioscience · doi:10.2741/2167 · Cited by 43
Rao, S., Garrett‐Sinha, L. A., Yoon, J. W., & Simon, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34245 · Cited by 55
Longmore, G. D., Pharr, P. N., & Lodish, H. F. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2266 · Cited by 46
Jego, G., Lanneau, D., De Thonel, A., Berthenet, K., Hazoumé, A., Droin, N., Hamman, A., Girodon, F., Bellaye, P.-S., Wettstein, G., et al. (2014) · Leukemia · doi:10.1038/leu.2014.63 · Cited by 42
DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development
Fan, T., Schmidtmann, A., Xi, S., Briones, V. R., Zhu, H., Suh, H. C., Gooya, J. M., Keller, J. R., Xu, H., Roayaei, J., et al. (2008) · Epigenetics · doi:10.4161/epi.3.3.6252 · Cited by 51
Hematopoietic stem cells and retroviral infection
Banerjee, P., Crawford, L. B., Samuelson, E., & Feuer, G. (2010) · Retrovirology · doi:10.1186/1742-4690-7-8 · Cited by 44
“1 has subsequently been shown to be involved in terminal myeloid differentiation, B and T-cell development, as well as maintenance of normal erythropoiesis and HSC development [91,92].”
BackgroundOrigins and properties of hematopoietic growth factor‐dependent cell lines
Ihle, J. N., & Askew, D. S. (1989) · The International Journal Of Cell Cloning · doi:10.1002/stem.5530070202 · Cited by 42
Analysis of the Modulation of Transcriptional Activity in Myelopoiesis and Leukemogenesis
Behre, G., Zhang, P., Zhang, D., & Tenen, D. G. (1999) · Methods · doi:10.1006/meth.1998.0733 · Cited by 45
Doubeikovski, A., Uzan, G., Doubeikovski, Z., Prandini, M.-H., Porteu, F., Gisselbrecht, S., & Dusanter-Fourt, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24300 · Cited by 41
Zhong, H., Takeda, A., Nazari, R., Shio, H., Blobel, G., & Yaseen, N. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412878200 · Cited by 46
Putative oncogenic role of the erythropoietin receptor in murine and human erythroleukemia cells
Chrétien, S., Moreau-Gachelin, F., Apiou, F., Courtois, G., Mayeux, P., Dutrillaux, B., CARTRON, J., Gisselbrecht, S., & Lacombe, C. (1994) · Blood · doi:10.1182/blood.v83.7.1813.1813 · Cited by 40
Self-citationThe ETS family member ERM contains an alpha-helical acidic activation domain that contacts TAFII60
Defossez, P. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.22.4455 · Cited by 40
ETS factors in prostate cancer
Qian, C., Li, D., & Chen, Y. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.009 · Cited by 46
Raich, N., & Roméo, P. (1993) · Stem Cells · doi:10.1002/stem.5530110204 · Cited by 43
Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1.
Choe, K. S., Radparvar, F., Matushansky, I., Rekhtman, N., Han, X., & Skoultchi, A. I. (2003) · PubMed · Cited by 51
The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter
Carvalho, M., & Derse, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3885-3890.1993 · Cited by 41
“The inappropriate expression of these ets-related proteins abrogates erythroblast differentiation and leads to immortalization (1, 12).”
BackgroundComprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer
Huang, J., Chen, W., Jie, Z., & Jiang, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.820568 · Cited by 38
“(5) from Friend hemoglobin disease, is an erythroblast transformation-specific (ETS) family transcription factor.”
BackgroundChoe, K. S., Ujhelly, O., Wontakal, S. N., & Skoultchi, A. I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077727 · Cited by 36
Yamada, T., Abe, M., Higashi, T., Yamamoto, H., Kihara-Negishi, F., Sakurai, T., Shirai, T., & Oikawa, T. (2001) · Blood · doi:10.1182/blood.v97.8.2300 · Cited by 36
Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus
Hasenkrug, K. J., Valenzuela, A., Letts, V. A., Nishio, J., Chesebro, B. W., & Frankel, W. N. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2617-2620.1995 · Cited by 38
“FV-induced erythroleukemia develops from this expanded population, usually following SFFV provirus integrations at theSpi1cellularoncogenelocus(2, 26 ).Inactivationofthep53 tumorsuppressorgeneisalsousuallyassociatedwiththetransformation of FV-induced erythroleukemias (2, 31).”
BackgroundCell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55
Li, J. P., Hu, H. O., Niu, Q., & Fang, C. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1714-1719.1995 · Cited by 38
“The uncontrolled erythroid proliferation eventually leads to the late stage of the disease, about 3 weeks postinfection, due to monoclonal or oligoclonal expansion of true leukemia cells with additional cytogenetic changes, such as the activation of the Spi-1 oncogene (29) and mutations in the p53 tumor suppressor gen…”
BackgroundSpi-1/PU.1 Oncoprotein Affects Splicing Decisions in a Promoter Binding-dependent Manner
Guillouf, C., Gallais, I., & Moreau-Gachelin, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512049200 · Cited by 30
Self-citation
Metadata
- Authors
- Moreau-Gachelin, F., Tavitian, A., & Tambourin, P.
- Affiliations
- Inserm (FR)
- Venue
- Nature
- Published
- 1988-01
- Volume
- 331
- Issue
- 6153
- Pages
- 277-280
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1975584136
- Cited by
- 447
- References
- 26
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 10 · 2012: 11
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Keywords
- SPI-1, spleen focus-forming virus, retroviral insertional mutagenesis, retroviral integration, chromosomal rearrangements, avian leukosis virus, murine leukemia virus, retroviral oncogenesis
- MeSH terms
- Animals, Cell Transformation, Viral, DNA, Neoplasm, DNA, Viral, Leukemia, Erythroblastic, Acute, Friend murine leukemia virus, Leukemia, Experimental, Mice, Inbred CBA, Mice, Inbred DBA, Leukemia Virus, Murine, Oncogenes, Proviruses, RNA, Messenger, RNA, Neoplasm, Spleen Focus-Forming Viruses, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.